% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Perucci:284091,
author = {Perucci, Luiza O. and Campi Santos, Patricia and Secchim
Ribeiro, Lucas and Souza, Danielle G. and Gomes, Karina B.
and Dusse, Luci M. S. and Sousa, Lirlândia P.},
title = {{L}ipoxin {A}4 {I}s {I}ncreased in the {P}lasma of
{P}reeclamptic {W}omen},
journal = {American journal of hypertension},
volume = {29},
number = {10},
issn = {0895-7061},
address = {Oxford},
publisher = {Oxford Univ. Press},
reportid = {DZNE-2026-00099},
pages = {1179 - 1185},
year = {2016},
abstract = {Excessive inflammation is involved in preeclampsia (PE)
pathogenesis. Lipoxin A4 (LXA4) is an eicosanoid that
counter-regulates inflammation. The main objective of this
study was to determine LXA4 plasma levels in PE women. The
correlations among LXA4 levels, ultrasensitive C-reactive
protein (us-CRP) levels, and clinical/laboratory parameters
of the studied participants were also investigated.LXA4
plasma levels were determined by ELISA in 23 nonpregnant, 26
normotensive pregnant, and 27 PE women (early PE (N = 10)
and late PE (N = 17)), according to gestational age (GA) at
clinical symptoms onset). The clinical/laboratory parameters
included in Spearman's correlation analysis were: systolic
and diastolic blood pressure (SBP and DBP, respectively),
lactate dehydrogenase (LDH) activity, platelet count,
proteinuria, and white blood cell count (WBC).LXA4 levels
were higher in PE women than in nonpregnant and normotensive
pregnant women, and similar between nonpregnant and
normotensive pregnant women. LXA4 plasma levels were higher
in early PE vs. normotensive pregnancy (GA < 34 weeks) and
in late PE vs. normotensive pregnancy (GA ≥ 34 weeks). No
significant differences were detected between early and late
PE. LXA4 levels were positively correlated with us-CRP
levels, SBP, DBP, and WBC. No significant correlation was
detected between LXA4 levels and the other laboratory
parameters.Chronic inflammation in PE, in spite of increased
levels of LXA4, points to a possible failure in this
regulatory pathway. Further studies are necessary to clarify
this issue and to evaluate the role of LXA4 and other
proresolving mediators of inflammation in the pathogenesis
of PE.},
keywords = {Adult / C-Reactive Protein: metabolism / Case-Control
Studies / Female / Humans / Lipoxins: blood / Pre-Eclampsia:
blood / Pre-Eclampsia: immunology / Pregnancy / Young Adult
/ blood pressure (Other) / hypertension (Other) /
inflammation (Other) / lipoxin A4 (Other) / preeclampsia
(Other) / resolution. (Other) / Lipoxins (NLM Chemicals) /
lipoxin A4 (NLM Chemicals) / C-Reactive Protein (NLM
Chemicals)},
ddc = {610},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
doi = {10.1093/ajh/hpw053},
url = {https://pub.dzne.de/record/284091},
}